Search

everythinglearnresearchcommunity

for

Search:↓

The mTOR pathway proteins are altered in the hair follicles of patients with Lichen Planopilaris and Frontal Fibrosing Alopecia.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

The document discusses various diseases of the outer ear, categorized by symptoms like redness, crusts, bumps, pus-filled lesions, lumps, ulcers, and hair loss.

The document concludes that different types of hair loss have specific treatments, and early diagnosis is crucial for preventing permanent hair loss.

Diagnosing and treating skin conditions is challenging, especially when drug reactions mimic other diseases.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

Combining hydroxychloroquine and pimecrolimus can effectively treat hair loss from discoid lupus.

Ciclosporin A effectively treated a cat's severe skin condition.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

The conclusion is that understanding how hair follicle stem cells live or die is important for maintaining healthy tissue and repairing injuries, and could help treat hair loss, but there are still challenges to overcome.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

K6hf is a unique protein found only in a specific layer of hair follicles.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

Finasteride is effective for male hair loss, teledermatology is accurate and accepted, and cyclosporin helps treat toxic epidermal necrolysis.

Cells in hair follicles help create fat cells in the skin by releasing a protein called Sonic Hedgehog.

The conclusion is that accurate diagnosis of different types of hair loss requires careful examination of tissue samples and understanding of clinical symptoms.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.

New treatments and technologies in laser medicine show promise for improving skin conditions, fat reduction, cancer treatment, wound healing, and hair restoration.

Hair growth and health are influenced by factors like age, environment, and nutrition, and are controlled by various molecular pathways. Red light can promote hair growth, and understanding these processes can help treat hair-related diseases.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

Different problems with hair stem cell renewal can lead to hair loss.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

New skin substitutes for treating severe burns and chronic wounds are being developed, but a permanent solution for deep wounds is not yet available commercially.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Healthy scalp leads to better hair quality and less damage.

Future research should focus on making bioengineered skin that completely restores all skin functions.

The article concludes that a thorough diagnosis and treatment plan, including medications, non-invasive methods, or surgery, is important for managing hair loss, with a combination of minoxidil and finasteride being particularly effective.

New treatments for hair loss, fertility, and wound healing are being explored.

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.